Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tremblay, Thomas
NCT04676737: TTHX1114(NM141) in Combination With DWEK/DSO	Completed	2	49	US	TTHX1114(NM141)	Trefoil Therapeutics, Inc.	Fuchs' Endothelial Dystrophy, Fuchs Dystrophy, Fuchs	11/22	01/23
OPTIC, NCT04812067: A Safety and Efficacy Trial of TTHX1114 in People With CED	Completed	2	41	US	TTHX1114	Trefoil Therapeutics, Inc.	Corneal Endothelial Dystrophy	08/23	10/23
EPI, NCT05769920: Dose Escalation TTHX1114 Ophthalmic Solution	Completed	1	8	US	TTHX1114(NM141) Ophthalmic Solution	Trefoil Therapeutics, Inc.	Corneal Epithelial Degeneration	04/23	04/23